Emcure Pharmaceuticals Limited (BOM:544210)
India flag India · Delayed Price · Currency is INR
1,392.90
+1.15 (0.08%)
At close: Dec 3, 2025

Emcure Pharmaceuticals Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Net Income
7,9316,8134,9825,3206,6223,921
Upgrade
Depreciation & Amortization
3,8793,7433,0322,5122,3483,137
Upgrade
Other Amortization
97.9897.9892.5689.04100.2896.1
Upgrade
Loss (Gain) From Sale of Assets
-4-382.35-71.923.334.08-4.23
Upgrade
Asset Writedown & Restructuring Costs
-----436.95
Upgrade
Loss (Gain) From Sale of Investments
-35.75-58.04-25.32-1.21--
Upgrade
Stock-Based Compensation
23.3919.8939.6752.7657.1663.48
Upgrade
Other Operating Activities
971.542,5262,4192,4151,4694,573
Upgrade
Change in Accounts Receivable
-1,876-1,434-1,506-3,398-1,729-3,301
Upgrade
Change in Inventory
-4,997-4,067-267.61663.85-3,072-3,413
Upgrade
Change in Accounts Payable
1,8601,7021,543-391.83,1572,315
Upgrade
Change in Other Net Operating Assets
-373.17-443.61736.2203.54-1,2761,053
Upgrade
Operating Cash Flow
7,4778,51710,9727,4697,6827,044
Upgrade
Operating Cash Flow Growth
-17.21%-22.38%46.91%-2.78%9.05%40.80%
Upgrade
Capital Expenditures
-2,404-2,218-2,758-3,906-3,782-1,254
Upgrade
Sale of Property, Plant & Equipment
40.65306.01315.3712.7531.21125.14
Upgrade
Cash Acquisitions
-2,804--3,451--2,751-1,116
Upgrade
Sale (Purchase) of Intangibles
-1,628-1,852-313.6-127.67-187.87-202.65
Upgrade
Investment in Securities
369.342,592-1,098-708.36-1,308-147.22
Upgrade
Other Investing Activities
27.06231.44179.46152.4109.4975.81
Upgrade
Investing Cash Flow
-6,399-940.01-7,125-4,577-7,888-2,518
Upgrade
Short-Term Debt Issued
--1,025976.791,759-
Upgrade
Long-Term Debt Issued
--5,4743,5763,7145,775
Upgrade
Total Debt Issued
7,810-6,5004,5535,4735,775
Upgrade
Short-Term Debt Repaid
--5,225----981.67
Upgrade
Long-Term Debt Repaid
--9,420-5,310-3,777-4,814-4,548
Upgrade
Total Debt Repaid
-4,665-14,645-5,310-3,777-4,814-5,529
Upgrade
Net Debt Issued (Repaid)
3,146-14,6451,190775.24659.17245.66
Upgrade
Issuance of Common Stock
186.747,79276.6---
Upgrade
Common Dividends Paid
-568.53--542.55-361.71-542.55-180.85
Upgrade
Other Financing Activities
-774.96-1,287-2,366-1,868-1,635-1,954
Upgrade
Financing Cash Flow
1,989-8,140-1,642-1,454-1,519-1,889
Upgrade
Foreign Exchange Rate Adjustments
90.7-20.49-20.02-1.281.86-46.17
Upgrade
Miscellaneous Cash Flow Adjustments
----1002,141-
Upgrade
Net Cash Flow
3,157-583.022,1851,336418.72,591
Upgrade
Free Cash Flow
5,0736,2998,2153,5633,9005,790
Upgrade
Free Cash Flow Growth
-22.93%-23.32%130.58%-8.65%-32.65%50.40%
Upgrade
Free Cash Flow Margin
6.00%7.98%12.34%5.95%6.66%11.50%
Upgrade
Free Cash Flow Per Share
26.7933.6845.4219.7021.5732.02
Upgrade
Cash Interest Paid
774.961,2872,0821,7861,5531,845
Upgrade
Cash Income Tax Paid
3,1972,4692,2372,0053,1122,004
Upgrade
Levered Free Cash Flow
3,0042,7773,6701,6252,2975,053
Upgrade
Unlevered Free Cash Flow
3,5323,5914,9402,7813,2165,765
Upgrade
Change in Working Capital
-5,387-4,243505.17-2,922-2,919-3,346
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.